Amneal Pharmaceuticals: Shares Still Feel Significantly Undervalued
Amneal Pharmaceuticals, Inc. offers strong growth prospects with undervalued stock, rising revenues, reduced debt, and key ...
Novo Nordisk (NVO) to be ‘Market Leader’ Despite ‘Horrifying’ Declines
We recently published a list of 10 Stocks Market Experts are Talking About These Days. In this article, we are going to take ...
Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements
Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in immuno-inflammation and immuno-oncology planned to enter IND-enabling ...
Investing Snacks11h
Eli Lilly: A Tiny Slip or a Big Pharma Play?
Eli Lilly's stock dipped slightly by -0.27% to close at $822.51, outperforming the S&P 500’s larger 1.07% drop. Despite a ...
Livewire Markets3h
7 ETFs to help weather market turbulence
With the S&P 500 briefly entering a technical correction and recession fears brewing, these ETFs could help when markets are ...
HUTCHMED (China) Limited: HUTCHMED Reports 2024 Full Year Results and Provides Business Updates
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED", the "Company" or "we") (HKEX: 13; Nasdaq/AIM: HCM) today reports its financial r ...